Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
The COVID-19 pandemic has been ongoing for more than 2 years now, and new variants such as Omicron are less susceptible to the vaccines developed against earlier lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Duration of immune protection of SARS-CoV-2 natural infection against reinfection in Qatar
We investigated duration of protection afforded by natural infection, the effect of viral immune evasion on duration of protection, and protection against severe reinfection, in Qatar, between February 28, 2020 and June 5, 2022.
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
These new subvariants carrying further mutations in their spike proteins raise concerns that they may further evade neutralizing antibodies.
Association of COVID-19 with New-Onset Alzheimer’s Disease
An infectious etiology of Alzheimer’s disease has been postulated for decades. It remains unknown whether SARS-CoV-2 viral infection is associated with increased risk for Alzheimer’s disease.
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
SARS-CoV-2 is primarily an airborne infection of the upper respiratory tract, which on reaching the lungs causes the severe acute respiratory disease, COVID-19.
Scientific Papers
Article
Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection
Scientific Papers
Article
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
The role of immune responses to previously seen endemic coronavirus epitopes in severe acute respiratory coronavirus 2 (SARS-CoV-2) infection and disease progression has not yet been determined.
Scientific Papers
Article
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
|
ESWI Airborne: Meet the Members
Walk the talk on immunisation
With a wealth of experience, Professor of Epidemiology and former Minister of Health, ESWI Board Member Roman Prymula gives a personal testimony of the COVID-19 pandemic and the different perspectives of politics vs science when it comes to health policy.
|
ESWI Airborne: Meet the Members
A mucosal perspective on pandemics
"Learn about the fascinating field of mucosal immunology, vaccine effectiveness, and the role of face-mask protection not from virus particles but “spiticles and snoticles”. Dr Peter Openshaw, ESWI Board Member and Professor of Experimental Medicine, ...